TrialBritish journal of cancer2012

Correlation of bevacizumab-induced hypertension and outcome in the BOXER study, a phase II study of capecitabine, oxaliplatin (CAPOX) plus bevacizumab as peri-operative treatment in 45 patients with poor-risk colorectal liver-only metastases unsuitable for upfront resection.

A Dewdney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.